- $180.39m
- $435.84m
- $716.30m
- 71
- 89
- 19
- 60
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 411 | 644 | 776 | 767 | 716 |
Cost of Revenue | |||||
Gross Profit | 319 | 439 | 521 | 570 | 493 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 393 | 592 | 776 | 664 | 698 |
Operating Profit | 17.8 | 52.5 | -0.045 | 102 | 18.2 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -6.97 | -0.861 | 5.74 | 104 | 50.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | -9.61 | -6.22 | -1.46 | 267 | 18.2 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -9.61 | -6.22 | -1.46 | 267 | 18.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -9.61 | -6.22 | -1.46 | 267 | 18.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.08 | 0.041 | 0.374 | 1.4 | -0.262 |